Quantcast

Latest Lupin Ltd. Stories

2010-10-14 15:30:00

ARDEE, Ireland, Oct. 14 /PRNewswire/ -- Warner Chilcott plc (Nasdaq: WCRX) and its subsidiary, Warner Chilcott Company, LLC, and Lupin Ltd. and its subsidiary, Lupin Pharmaceuticals, Inc., today announced that they have entered into a settlement agreement to resolve pending patent litigations involving Warner Chilcott's oral contraceptive products, Loestrin® 24 Fe and Femcon® Fe (the "Settlement Agreement"). Under the terms of the Settlement Agreement,...

2010-08-03 10:53:00

BALTIMORE, Aug. 3 /PRNewswire/ -- Lupin Ltd. today announced the appointment of Paul McGarty as President of its U.S. Subsidiary, Lupin Pharmaceuticals, Inc. Paul has over 25 years experience in the Pharmaceutical Industry spanning across brand and specialty pharmaceutical companies. Most recently, as the CEO of Nycomed U.S., Paul successfully transformed the company from a topical manufacturer into a Dermatology Specialty Company with a brand & generic business. Under his leadership...

2010-01-20 10:09:00

MUMBAI, India, Jan. 20 /PRNewswire/ -- Pharma major, Lupin Ltd announced today that it has received official communication from the US FDA on the satisfactory resolution of the Warning Letter issued earlier to its Mandideep site. The company had received a Warning letter for its Mandideep site in May 2009. In the ensuing seven months, the company made significant enhancements and took appropriate corrective actions. The facility was re-inspected in November 2009 and the company was able to...

2009-10-05 09:57:00

MUMBAI, India, Oct. 5 /PRNewswire-FirstCall/ -- Pharma Major, Lupin Ltd today announced that it has granted Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) the exclusive rights for the United States to its bioadhesive drug delivery technology for use with Rifaximin. Lupin and Salix have entered into an agreement under which the two companies will collaborate in the development and commercialization of an extended release product incorporating Rifaximin and utilizing Lupin's proprietary...

2009-09-29 15:43:00

MUMBAI, India, Sept. 29 /PRNewswire-FirstCall/ -- Pharmaceutical Major, Lupin Ltd. announced today the acquisition of US rights for Antara® (Fenofibrate Capsules 43 mg and 130 mg). Lupin acquired the product from Oscient Pharmaceuticals on September 25, 2009, under the procedures of the U.S. Bankruptcy Court. Antara recorded net sales of US $ 70 million for 2008 (Source: IMS Dec 2008). Lupin paid $ 38.61 million for the product and related assets inclusive of...

2009-08-03 06:00:00

ARDEE, Ireland, Aug. 3 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it has received two Paragraph IV Certification Notices from Lupin Ltd. ("Lupin"). The Paragraph IV Certification Notices advise the Company of the filing of Abbreviated New Drug Applications (ANDAs) by Lupin for generic versions of the Company's oral contraceptives, LOESTRIN 24 FE and FEMCON FE. LOESTRIN 24 FE, which was launched in March of 2006, is protected by U.S. Patent No....

2008-12-17 11:52:00

MUMBAI, India, Dec. 17 /PRNewswire/ -- Pharma Major, Lupin Ltd. announced today that it has settled all ongoing Hatch-Waxman litigation relating to Desloratadine tablets, the generic version of Schering-Plough's "Clarinex"(R) tablets. As per the terms of the settlement, Lupin Ltd. will be licensed under the relevant Desloratadine patents, and free to commercially launch its generic Desloratadine product, on July 1, 2012, or earlier in certain circumstances. Lupin had earlier filed a...

2008-08-19 15:01:22

MUMBAI, India and BALTIMORE, Aug. 19 /PRNewswire/ -- Lupin Ltd. announced today that the Company has entered into a multi-year promotion and marketing agreement for the AeroChamber Plus(R) line of products with Forest Laboratories, Inc. Under the terms of the agreement, Lupin Pharmaceuticals, Inc., USA, will use its 50 person sales force to promote the product to pediatricians. AeroChamber Plus(R) is a Valved Holding Chamber (VHC) device that is used with metered dose inhalers to improve...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.